Fig. 2From: High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasisAssociation between the HSPB1 expression levels and clinical characteristics in patients with breast cancer. The relationship between HSPB1 expression and clinical characteristics, including the patient A status (tumor or normal), B age (≤ 60 and > 60), C T stage (T1, T2, T3, or T4), D N stage (N0, N1, N2, or N3), E M stage (M0 or M1), F pathologic stage (stage I, stage II, or stage III), G estrogen receptor (ER; negative or positive), H progesterone receptor (PR; negative or positive). I human epidermal growth factor receptor 2 (HER2; negative or positive)Back to article page